Business
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
David E. I. Pyott David E. I. Pyott, former Chairman and CEO of Allergan, Inc., was appointed to Tarsus Pharmaceuticals' Board of Directors. IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical industry and former Chairman and CEO of Allergan, Inc., to its Board of Directors. “David is one of the most accomplished leaders in eye care, with a strong
About this update from Tarsus Pharmaceuticals, Inc.
[{"type":"image","alt":"Tarsus Pharmaceuticals, Inc","displaySize":"","headline":null,"caption":"Tarsus Pharmaceuticals, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":218,"url":"https://media.zenfs.com/en/globenewswire.com/4482918fc3608261626e37d219861c79"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YAv_H0H0DM_L1x1BaB8NHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/4482918fc3608261626e37d219861c79","width":300,"height":218}},"lazy":false},{"type":"text","content":"David E. I. Pyott","length":17,"tagName":"p"},{"type":"image","alt":"David E. I. Pyott, former Chairman and CEO of Allergan, Inc., was appointed to Tarsus Pharmaceuticals' Board of Directors.","displaySize":"","headline":null,"caption":"David E. I. Pyott, former Chairman and CEO of Allergan, Inc., was appointed to Tarsus Pharmaceuticals' Board of Directors.","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":3000,"height":2400,"url":"https://media.zenfs.com/en/globenewswire.com/dd59c0744f094a6939b2ebf4b5e3abd3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xYPwVfZpf0micTeXcGnYFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/dd59c0744f094a6939b2ebf4b5e3abd3","width":960,"height":768},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4e1Cy6HlsMB5s69zu7GM8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTIwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/dd59c0744f094a6939b2ebf4b5e3abd3","width":1200,"height":960}}},{"type":"text","content":"IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical industry and former Chairman and CEO of Allergan, Inc., to its Board of Directors.","length":285,"tagName":"p"},{"type":"text","content":"“David is one of the most accomplished leaders in eye care, with a strong track record of translating innovation into global impact,” said Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman of Tarsus. “His experience building some of the most successful franchises in our industry will be invaluable as we scale XDEMVY, advance our pipeline and position Tarsus for sustained growth. We are honored to ...